Study Stopped
The DSAEK procedure was discontinued as the standard of care for the intended cohort.
Using the Optovue OCT to Select IOL Power
Evaluation of Total Corneal Power Calculations for Intraocular Lens Selection Using the Optovue OCT in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Patients
1 other identifier
observational
50
1 country
1
Brief Summary
Many patients with endothelial dysfunction also present with cataracts. It is therefore common practice to perform cataract extraction and intraocular lens (IOL) implantation during the same operation and immediately prior to Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK), in order to minimize trips to the operating room and the associated risks of ocular surgery. However, the unique posterior corneal anatomy of the DSAEK recipient makes it difficult to predict pre-operatively the proper power of IOL to place, and some patients end up with a mismatched lens that requires spectacle correction. The current gold standard for IOL power calculation (A-Scan optical biometry) takes measurements of the anterior surface of the cornea and makes assumptions about the posterior surface that are violated by the unique hourglass shape of the donor DSAEK graft. New optical coherence tomography (OCT) technology provides us with the ability to measure curvature in both the anterior and posterior aspects of the cornea in order to generate an IOL calculation that has the potential to give more accurate results for our DSAEK patients. The investigators will be using the Optovue to perform corneal power analysis on patients who have already received DSAEK and cataract surgery, in order to compare the post-op Optovue power calculations to the pre-operative power calculations provided by the A-Scan. If the OCT is shown to provide accurate IOL power calculations, then some patients might be better served by a two-stage procedure where DSAEK is performed and then followed six months later by cataract surgery using the OCT to calculate IOL power.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2010
CompletedFirst Submitted
Initial submission to the registry
May 25, 2011
CompletedFirst Posted
Study publicly available on registry
May 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2016
CompletedMarch 13, 2017
March 1, 2017
5.8 years
May 25, 2011
March 8, 2017
Conditions
Keywords
Study Arms (1)
Triple Procedure
All qualifying patients will have received DSAEK with concurrent cataract extraction and intraocular lens placement. Data collection will occur between 6-18 months post-operation.
Eligibility Criteria
All study subjects will have received Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for Fuchs' Endothelial Dystrophy, together with concurrent cataract surgery. Data collection will occur between 6 and 18 months following surgery.
You may qualify if:
- year of age or older
- Diagnosis of Fuchs' Endothelial Dystrophy with cataract
- Recent history of DSAEK with concurrent phacoemulsification \& intraocular lens (IOL) implantation
You may not qualify if:
- Diagnosis of ocular comorbidity that might be limiting to visual acuity (glaucoma, retinal disease, surface irregularities, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Legacy Health Systemlead
- Devers Eye Institutecollaborator
- Optovuecollaborator
- Lions VisionGift Researchcollaborator
Study Sites (1)
Devers Eye Institute
Portland, Oregon, 97210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark A Terry, MD
Devers Eye Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Corneal Services
Study Record Dates
First Submitted
May 25, 2011
First Posted
May 26, 2011
Study Start
November 9, 2010
Primary Completion
September 9, 2016
Study Completion
September 9, 2016
Last Updated
March 13, 2017
Record last verified: 2017-03